138 related articles for article (PubMed ID: 24085786)
1. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.
Gibbons AV; Lin JE; Kim GW; Marszalowicz GP; Li P; Stoecker BA; Blomain ES; Rattan S; Snook AE; Schulz S; Waldman SA
Cancer Res; 2013 Nov; 73(22):6654-66. PubMed ID: 24085786
[TBL] [Abstract][Full Text] [Related]
2. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
Witek M; Blomain ES; Magee MS; Xiang B; Waldman SA; Snook AE
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1188-95. PubMed ID: 24661671
[TBL] [Abstract][Full Text] [Related]
3. GUCY2C-targeted cancer immunotherapy: past, present and future.
Snook AE; Magee MS; Waldman SA
Immunol Res; 2011 Dec; 51(2-3):161-9. PubMed ID: 22038530
[TBL] [Abstract][Full Text] [Related]
4. Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8
Xiang B; Baybutt TR; Berman-Booty L; Magee MS; Waldman SA; Alexeev VY; Snook AE
J Immunol; 2017 May; 198(9):3507-3514. PubMed ID: 28341670
[TBL] [Abstract][Full Text] [Related]
5. Intestinal neuropod cell GUCY2C regulates visceral pain.
Barton JR; Londregan AK; Alexander TD; Entezari AA; Bar-Ad S; Cheng L; Lepore AC; Snook AE; Covarrubias M; Waldman SA
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548082
[TBL] [Abstract][Full Text] [Related]
6. Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis.
Blomain ES; Lin JE; Kraft CL; Trela UT; Rock JM; Aing AS; Snook AE; Waldman SA
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):557-64. PubMed ID: 23971873
[TBL] [Abstract][Full Text] [Related]
7. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
Marszalowicz GP; Snook AE; Magee MS; Merlino D; Berman-Booty LD; Waldman SA
Oncotarget; 2014 Oct; 5(19):9460-71. PubMed ID: 25294806
[TBL] [Abstract][Full Text] [Related]
8. Molecular staging estimates occult tumor burden in colorectal cancer.
Mejia A; Schulz S; Hyslop T; Weinberg DS; Waldman SA
Adv Clin Chem; 2010; 52():19-39. PubMed ID: 21275338
[TBL] [Abstract][Full Text] [Related]
9. GUCY2C molecular staging personalizes colorectal cancer patient management.
Gong JP; Schulz S; Hyslop T; Waldman SA
Biomark Med; 2012 Jun; 6(3):339-48. PubMed ID: 22731908
[TBL] [Abstract][Full Text] [Related]
10. GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.
Mejia A; Schulz S; Hyslop T; Weinberg DS; Waldman SA
Expert Rev Mol Diagn; 2009 Nov; 9(8):777-85. PubMed ID: 19895223
[TBL] [Abstract][Full Text] [Related]
11. TCR Retrogenic Mice as a Model To Map Self-Tolerance Mechanisms to the Cancer Mucosa Antigen GUCY2C.
Abraham TS; Flickinger JC; Waldman SA; Snook AE
J Immunol; 2019 Feb; 202(4):1301-1310. PubMed ID: 30642983
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3.
Rampuria P; Mosyak L; Root AR; Svenson K; Agostino MJ; LaVallie ER
Sci Rep; 2023 Aug; 13(1):13408. PubMed ID: 37591971
[TBL] [Abstract][Full Text] [Related]
13. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.
Davis H; Irshad S; Bansal M; Rafferty H; Boitsova T; Bardella C; Jaeger E; Lewis A; Freeman-Mills L; Giner FC; Rodenas-Cuadrado P; Mallappa S; Clark S; Thomas H; Jeffery R; Poulsom R; Rodriguez-Justo M; Novelli M; Chetty R; Silver A; Sansom OJ; Greten FR; Wang LM; East JE; Tomlinson I; Leedham SJ
Nat Med; 2015 Jan; 21(1):62-70. PubMed ID: 25419707
[TBL] [Abstract][Full Text] [Related]
14. The Intestinal Tract Brush Border in Young Children Uniformly Expresses Guanylate Cyclase C.
Di Guglielmo MD; Holbrook J; Stabley D; Robbins KM; Boyce B; Hardy H; Adeyemi A
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):154-162. PubMed ID: 36735491
[TBL] [Abstract][Full Text] [Related]
15. Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo.
Radulescu S; Brookes MJ; Salgueiro P; Ridgway RA; McGhee E; Anderson K; Ford SJ; Stones DH; Iqbal TH; Tselepis C; Sansom OJ
Cell Rep; 2012 Aug; 2(2):270-82. PubMed ID: 22884366
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 is a critical mediator of intestinal transformation.
van der Heijden M; Zimberlin CD; Nicholson AM; Colak S; Kemp R; Meijer SL; Medema JP; Greten FR; Jansen M; Winton DJ; Vermeulen L
Nat Commun; 2016 Mar; 7():10916. PubMed ID: 26956214
[TBL] [Abstract][Full Text] [Related]
17. Microenvironmental control of stem cell fate in intestinal homeostasis and disease.
Biswas S; Davis H; Irshad S; Sandberg T; Worthley D; Leedham S
J Pathol; 2015 Oct; 237(2):135-45. PubMed ID: 25974319
[TBL] [Abstract][Full Text] [Related]
18. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
Flickinger JC; Rappaport JA; Barton JR; Baybutt TR; Pattison AM; Snook AE; Waldman SA
Biomark Med; 2021 Feb; 15(3):201-217. PubMed ID: 33470843
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant.
Scott W; Wong IGY; Cramer J; Horton D; Basel D; Teng RJ; Muriello M; Elkadri A
Am J Med Genet A; 2024 Apr; 194(4):e63489. PubMed ID: 38058249
[TBL] [Abstract][Full Text] [Related]
20. The diverse nature of intestinal fibroblasts in development, homeostasis, and disease.
Brügger MD; Basler K
Trends Cell Biol; 2023 Oct; 33(10):834-849. PubMed ID: 37080817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
